Minhee Kang

Biography

Education and Training

• Ph.D., Biostatistics
  Harvard University
• Sc.B., Applied Mathematics
  Brown University
• M.S., Operations Research
  Cornell University

Awards and Honors

• Howard Hughes Medical Institute Predoctoral Fellowship in Biological Sciences, 1998 - 2003

Publications

• Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.

  Epeldegui M, Chang D, Lee J, Magpantay LI, Borok M, Bukuru A, Busakhala N, Godfrey C, Hosseinipour MC, Kang M, Kanyama C, Langat D, Mngqibisa R, Mwelase N, Nyirenda M, Samaneka W, Hoagland B, Campbell TB, Martínez-Maza O, Krown SE. J Acquir Immune Defic Syndr 2023 10 01

• Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV.

  Kang M, Price JC, Peters MG, Lewin SR, Sulkowski M. J Virus Erad 2023

• Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus.

  Marks KM, Kang M, Umbleja T, Avihingsanon A, Sugandhavesa P, Cox AL, Vigil K, Perazzo H, Price JC, Katsidzira L, Vernon C, Alston-Smith B, Sherman KE. Clin Infect Dis 2023 08 14

• Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS).

  Wyles DL, Kang M, Matining RM, Murphy RL, Peters MG. Open Forum Infect Dis 2023

• Effects of Sex, Existing Antibodies, and HIV-1-Related and Other Baseline Factors on Antibody Responses to Quadrivalent HPV Vaccine in Persons With HIV.

  Kang M, Umbleja T, Ellsworth G, Aberg J, Wilkin T. J Acquir Immune Defic Syndr 2022 04 01